LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Carbohydrate doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N-heteroaryl-purin-6-amines, and pharmaceutical compositions and

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N-Methanesulfonic acid derivatives of 3-demethoxyistamycin B

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N-pyrazole A 2A receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N-pyrazole A 2A receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N-pyrazole A2A adenosine receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N-pyrazole A2A receptor agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N-substituted pseudo-aminosugars and pharmaceutical compositions

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N-substituted pyrazole-O-glycoside derivatives and...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N-sulfonyl carboxylic amide derivative including an N-containing

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N-sulphated hyaluronic acid compounds, derivatives thereof...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N-[[5-(trifluoromethyl)-6-methoxy-1-naphthalenyl]-thioxomethyl a

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N.sub.6 -Benzopyrano-and benzothiopyrano adenosines and methods

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N.sup.4 -(substituted-oxycarbonyl)-5'-deoxy-5-fluorocytidine com

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N.sup.6 -(benzothien-3-yl)ethyl adenosine; N.sup.6 -(benzothien-

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N.sup.6 -(epoxynorborn-2-yl) adenosines as A.sub.1 adenosine rec

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N.sup.6 -acenaphthyl adenosines and analogs thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N.sup.6 -acenaphthyl adenosines and analogs thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N.sup.6 -bicycloadenosines and methods of use

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

N.sup.6 -dihydroxypropyladenosines